<DOC>
	<DOCNO>NCT01775059</DOCNO>
	<brief_summary>This multi-center , non-randomized , interventional study subject use Integrated sensor infusion set MiniLink Transmitter Medtronic Paradigm® VEO™ insulin pump ( Sensor augment pump ) 15 day . The purpose study collect performance data Integrated sensor infusion set approximately 15 day , intention subject wear 5 set 3 day .</brief_summary>
	<brief_title>Collection Performance Data From Integrated Sensor Infusion Set . TRIAL 4</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Subject 18 year age old time screen Subject clinical diagnosis insulin require diabetes , determine investigator . Subject currently use Medtronic Paradigm Sensor Augmented insulin pump minimum 3 month time enrollment . Subject Continuous Glucose Monitoring experience ( min 30 % CGM use within month prior enrollment ) . Subject average 3 SMBG per day ( verified via CareLink ) month prior enrollment . Subject willing wear study device duration study Subject willing perform frequent ( min 7 per day ) SMBGs study device wear Subject willing keep short diary device wear . Female subject pregnant , per urine pregnancy test perform time enrollment woman child bear age . Female subject plan become pregnant course study . Subject unable tolerate tape adhesive area placement study device . Subject unresolved adverse skin condition area placement study device ( e.g . psoriasis , rash , Staphylococcus infection ) . The subject deem appropriate candidate study investigator reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>